• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NF1 基因沉默可诱导雪旺细胞和非雪旺细胞中血管内皮生长因子表达上调。

NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells.

机构信息

Department of Dermatology, Faculty of Medicine, University of Tsukuba, Tennodai, Tsukuba, Japan.

出版信息

Exp Dermatol. 2013 Apr;22(4):262-5. doi: 10.1111/exd.12115.

DOI:10.1111/exd.12115
PMID:23528211
Abstract

Neurofibromatosis type I (NF1) is associated with typical hypervascular tumors, including neurofibroma, glioma, malignant peripheral nerve sheath tumors (MPNST) and glomus tumors. Previously, we and other groups reported that neurofibromas showed high-level expression of vascular endothelial growth factor (VEGF), a potent angiogenic factor involved in neovascularization. However, the molecular mechanism underlying the upregulation of VEGF in neurofibromas remains unclear. In this study, we examined the effects of Nf1 gene silencing on VEGF expression in Schwann cell and non-Schwann cell line and the upstream mTOR-HIF-1α - VEGF pathway in Schwann cell line. The results indicated that Nf1 gene silencing by lentiviral-mediated RNA interference resulted in elevated expression of VEGF, HIF-1α and phosphorylated mTOR at the protein level. The results obtained from Nf1 gene silencing in murine Schwann cell line analogously suggest that NF1 gene haploinsufficiency in human tumor Schwann cells may directly elicit upregulation of VEGF expression without the tumor microenvironment by activation of the mTOR-HIF-1α - VEGF pathway. We also showed that interleukin-6 is upregulated in Nf1 gene knock-down Schwann cells at the protein level.

摘要

神经纤维瘤病 1 型(NF1)与典型的高血管性肿瘤有关,包括神经纤维瘤、神经胶质瘤、恶性外周神经鞘肿瘤(MPNST)和血管球瘤。以前,我们和其他研究小组报道称,神经纤维瘤表现出高水平的血管内皮生长因子(VEGF)表达,VEGF 是一种参与新血管形成的有效的血管生成因子。然而,神经纤维瘤中 VEGF 上调的分子机制尚不清楚。在这项研究中,我们研究了 Nf1 基因沉默对施万细胞和非施万细胞系中 VEGF 表达以及施万细胞系中 mTOR-HIF-1α-VEGF 通路的上游的影响。结果表明,通过慢病毒介导的 RNA 干扰沉默 Nf1 基因导致 VEGF、HIF-1α 和磷酸化 mTOR 在蛋白水平上的表达升高。通过小鼠施万细胞系中的 Nf1 基因沉默获得的结果同样表明,人肿瘤施万细胞中 NF1 基因杂合不足可能通过 mTOR-HIF-1α-VEGF 通路的激活,在没有肿瘤微环境的情况下,直接引起 VEGF 表达的上调。我们还表明,白细胞介素-6 在 Nf1 基因敲低的施万细胞中在蛋白水平上上调。

相似文献

1
NF1 gene silencing induces upregulation of vascular endothelial growth factor expression in both Schwann and non-Schwann cells.NF1 基因沉默可诱导雪旺细胞和非雪旺细胞中血管内皮生长因子表达上调。
Exp Dermatol. 2013 Apr;22(4):262-5. doi: 10.1111/exd.12115.
2
The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.血管生成因子中期因子在神经纤维瘤病1型(NF1)缺陷的施万细胞中异常表达,并且是神经纤维瘤来源细胞的促分裂原。
Oncogene. 2001 Jan 4;20(1):97-105. doi: 10.1038/sj.onc.1204026.
3
NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.NF1 缺失导致来源于神经纤维瘤病 1 相关恶性外周神经鞘瘤的雪旺细胞中 Bcl-xL 的上调。
Int J Oncol. 2013 Feb;42(2):657-66. doi: 10.3892/ijo.2012.1751. Epub 2012 Dec 24.
4
AQP1 expression alterations affect morphology and water transport in Schwann cells and hypoxia-induced up-regulation of AQP1 occurs in a HIF-1α-dependent manner.水通道蛋白 1(AQP1)表达的改变会影响施万细胞的形态和水转运,而缺氧诱导的 AQP1 上调是依赖于低氧诱导因子 1α(HIF-1α)的。
Neuroscience. 2013 Nov 12;252:68-79. doi: 10.1016/j.neuroscience.2013.08.006. Epub 2013 Aug 12.
5
Vascular endothelial growth factor, basic fibroblast growth factor and epithelial growth factor receptor in peripheral nerve sheath tumors of neurofibromatosis type 1.1型神经纤维瘤病外周神经鞘瘤中的血管内皮生长因子、碱性成纤维细胞生长因子和上皮生长因子受体
Anticancer Res. 2015 Jan;35(1):137-44.
6
In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.1型神经纤维瘤病肿瘤和雪旺细胞中类固醇激素的体外研究。
Mol Carcinog. 2007 Jul;46(7):512-23. doi: 10.1002/mc.20236.
7
The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.WNT 信号通路的激活是神经纤维瘤病 1 型肿瘤发生的标志。
Clin Cancer Res. 2014 Jan 15;20(2):358-71. doi: 10.1158/1078-0432.CCR-13-0780. Epub 2013 Nov 11.
8
Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1.胰岛素样生长因子-1受体(IGF-1R)在1型神经纤维瘤病外周神经鞘瘤中的表达
Anticancer Res. 2007 Jul-Aug;27(4A):2085-90.
9
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.厚朴酚通过抑制低氧诱导因子-1α/血管内皮生长因子信号通路抑制人膀胱癌的血管生成。
Biochem Pharmacol. 2013 May 1;85(9):1278-87. doi: 10.1016/j.bcp.2013.02.009. Epub 2013 Feb 14.
10
Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.神经纤维瘤病 1 型中神经纤维瘤蛋白表达减少促进上皮间质转化。
Exp Dermatol. 2010 Aug;19(8):e136-41. doi: 10.1111/j.1600-0625.2009.01017.x.

引用本文的文献

1
Genomic spectra of lymphovascular invasion in breast cancer.乳腺癌中淋巴管浸润的基因组图谱。
Chin J Cancer Res. 2025 Apr 30;37(2):138-153. doi: 10.21147/j.issn.1000-9604.2025.02.02.
2
Anlotinib combined with pembrolizumab as first-line treatment for advanced pulmonary sarcomatoid carcinoma: a case report and literature review.安罗替尼联合帕博利珠单抗作为晚期肺肉瘤样癌一线治疗的病例报告及文献复习
Front Oncol. 2023 Oct 18;13:1241475. doi: 10.3389/fonc.2023.1241475. eCollection 2023.
3
Neurologic orphan diseases: Emerging innovations and role for genetic treatments.
神经罕见病:新兴创新与基因治疗的作用
World J Exp Med. 2023 Sep 20;13(4):59-74. doi: 10.5493/wjem.v13.i4.59.
4
Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial.EORTC-26101 试验中进展性胶质母细胞瘤的 DNA 甲基化和下一代测序的预后标志物。
Clin Cancer Res. 2023 Oct 2;29(19):3892-3900. doi: 10.1158/1078-0432.CCR-23-0926.
5
Hypoxia in Skin Cancer: Molecular Basis and Clinical Implications.皮肤癌中的缺氧:分子基础与临床意义。
Int J Mol Sci. 2023 Feb 23;24(5):4430. doi: 10.3390/ijms24054430.
6
RAS and beyond: the many faces of the neurofibromatosis type 1 protein.RAS 及其他:神经纤维瘤病 1 型蛋白的多面性。
Dis Model Mech. 2022 Feb 1;15(2). doi: 10.1242/dmm.049362. Epub 2022 Feb 21.
7
Advancement in research and therapy of mutant malignant tumors.突变恶性肿瘤的研究与治疗进展
Cancer Cell Int. 2020 Oct 9;20:492. doi: 10.1186/s12935-020-01570-8. eCollection 2020.
8
Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1.甲磺酸伊马替尼的早期给药可减少丛状神经纤维瘤肿瘤负担,并在 1 型神经纤维瘤病的小鼠模型中停药后获得持久的效果。
Pediatr Blood Cancer. 2020 Aug;67(8):e28372. doi: 10.1002/pbc.28372. Epub 2020 May 27.
9
A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1-associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study.一项评估连续口服 mTOR 抑制剂依维莫司治疗复发性、影像学进展性 1 型神经纤维瘤病相关小儿低度胶质瘤的 II 期研究:一项神经纤维瘤病临床试验联盟研究。
Neuro Oncol. 2020 Oct 14;22(10):1527-1535. doi: 10.1093/neuonc/noaa071.
10
Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.神经纤维瘤病缺失诱导血管内皮细胞增殖和视网膜新生血管形成。
Invest Ophthalmol Vis Sci. 2018 May 1;59(6):2520-2528. doi: 10.1167/iovs.17-22588.